These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 18382182)
21. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Pahwa R; Lyons KE Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174 [TBL] [Abstract][Full Text] [Related]
22. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Zesiewicz TA; Ward CL; Hauser RA; Salemi JL; Siraj S; Wilson MC; Sullivan KL Mov Disord; 2007 Aug; 22(11):1660-3. PubMed ID: 17580330 [TBL] [Abstract][Full Text] [Related]
23. Topiramate in migraine prevention: results of a large controlled trial. Silberstein SD; Neto W; Schmitt J; Jacobs D; Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395 [TBL] [Abstract][Full Text] [Related]
24. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Kushner SF; Khan A; Lane R; Olson WH Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977 [TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. Lindley SE; Carlson EB; Hill K J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136 [TBL] [Abstract][Full Text] [Related]
26. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J; Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947 [TBL] [Abstract][Full Text] [Related]
27. Topiramate for migraine prevention: a randomized controlled trial. Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D; JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912 [TBL] [Abstract][Full Text] [Related]
28. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor. Handforth A; Martin FC Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011 [TBL] [Abstract][Full Text] [Related]
30. Time course of adverse events most commonly associated with topiramate for migraine prevention. Láinez MJ; Freitag FG; Pfeil J; Ascher S; Olson WH; Schwalen S Eur J Neurol; 2007 Aug; 14(8):900-6. PubMed ID: 17662012 [TBL] [Abstract][Full Text] [Related]
31. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Chengappa KN; Gershon S; Levine J Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568 [TBL] [Abstract][Full Text] [Related]
32. Topiramate improves health-related quality of life when used to prevent migraine. Diamond M; Dahlöf C; Papadopoulos G; Neto W; Wu SC Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
34. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related]
35. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. Muehlbacher M; Nickel MK; Kettler C; Tritt K; Lahmann C; Leiberich PK; Nickel C; Krawczyk J; Mitterlehner FO; Rother WK; Loew TH; Kaplan P Clin J Pain; 2006; 22(6):526-31. PubMed ID: 16788338 [TBL] [Abstract][Full Text] [Related]
36. Assessing the ability of topiramate to improve the daily activities of patients with migraine. Brandes JL; Kudrow DB; Rothrock JF; Rupnow MF; Fairclough DL; Greenberg SJ Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556 [TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor. Frima N; Grünewald RA Clin Neuropharmacol; 2006; 29(2):94-6. PubMed ID: 16614542 [TBL] [Abstract][Full Text] [Related]
38. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769 [TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled trial of topiramate for pathological gambling. Berlin HA; Braun A; Simeon D; Koran LM; Potenza MN; McElroy SL; Fong T; Pallanti S; Hollander E World J Biol Psychiatry; 2013 Mar; 14(2):121-8. PubMed ID: 21486110 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. Tonstad S; Tykarski A; Weissgarten J; Ivleva A; Levy B; Kumar A; Fitchet M Am J Cardiol; 2005 Jul; 96(2):243-51. PubMed ID: 16018851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]